EPISODE · Oct 8, 2024 · 31 MIN
Noticing Neffy – A ‘Transformative Treatment’ For Type 1 Allergies
from Citeline Podcasts · host Norstella
Richard Lowenthal, co-founder, and CEO of ARS Pharma, highlights the crucial unmet need for needle-free injections. Challenging issues posed by current epinephrine injectors, In Vivo questions the current and future progression of Neffy.
What this episode covers
Richard Lowenthal, co-founder, and CEO of ARS Pharma, highlights the crucial unmet need for needle-free injections. Challenging issues posed by current epinephrine injectors, In Vivo questions the current and future progression of Neffy.
NOW PLAYING
Noticing Neffy – A ‘Transformative Treatment’ For Type 1 Allergies
No transcript for this episode yet
Similar Episodes
Jun 15, 2022 ·8m
May 25, 2022 ·20m
May 19, 2022 ·16m
May 15, 2022 ·34m
May 12, 2022 ·1m